PILRA regulates microglial immunometabolism to reduce disease pathology as a candidate therapeutic target for Alzheimer's disease
Lipidomics data analysis for the manuscript “PILRA regulates microglial immunometabolism to reduce disease pathology as a candidate therapeutic target for Alzheimer’s disease.” This archive contains a zipped, self-contained HTML project that includes the data and R code used for the analyses and visualizations presented in the manuscript.
Institutions
- Denali Therapeutics (United States) (US)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-09-18
- DOI
- https://doi.org/10.5281/zenodo.17155919
- Primary Topic
- Geochemistry and Geologic Mapping
- Type
- article
- Field-Weighted Citation Impact
- 0.00